New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
05:34 EDTREGN, BAYRYBayer, Regeneron announce regulatory submission of Eylea in Japan
Regeneron Pharmaceuticals (REGN) announced that Bayer HealthCare's (BAYRY) Japanese subsidiary, Bayer Yakuhin, has submitted an application for marketing authorization for Eylea Injection for the treatment of patients with diabetic macular edema, or DME, to the Japanese Ministry of Health, Labour and Welfare.
News For BAYRY;REGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
06:43 EDTREGNRegeneron price target raised to $527 from $445 at Leerink
Subscribe for More Information
April 22, 2015
12:49 EDTBAYRYEU proposes new law that allows states to ban biotech crops, WSJ reports
Subscribe for More Information
07:07 EDTBAYRYEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
April 20, 2015
09:20 EDTREGNLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
07:18 EDTBAYRYAmerican Academy of Neurology to hold annual meeting
Subscribe for More Information
April 16, 2015
12:19 EDTBAYRYBayer downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
April 15, 2015
07:41 EDTBAYRYEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use